AURO-RAMIPRIL TABLETS 1.25 ramipril 1.25mg tablet blister pack

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

ramipril, Quantity: 1.25 mg

から入手可能:

Arrotex Pharmaceuticals Pty Ltd

INN（国際名）:

Ramipril

医薬品形態:

Tablet, uncoated

構図:

Excipient Ingredients: lactose monohydrate; pregelatinised maize starch; sodium stearylfumarate; croscarmellose sodium; sodium bicarbonate

投与経路:

Oral

パッケージ内のユニット:

28, 30

処方タイプ:

(S4) Prescription Only Medicine

適応症:

? Treatment of hypertension. Data are currently not available to support the use of Ramipril in renovascular hypertension. ,? Post MI heart failure ,? Prevention of progressive renal failure in patients with persistent proteinuria in excess of 1 g/day. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or the need for revascularisation procedures in patients 55 years of age or more who have clinical evidence of coronary artery disease, stroke, or peripheral vascular disease. ,? For reducing the risk of myocardial infarction, stroke, cardiovascular death or revascularization procedures in diabetic patients 55 years or more with one or more of the following risk factors: systolic blood pressure >160mmHg or diastolic blood pressure >90mmHg (or on antihypertensive treatment); total cholesterol >5.2mmol/L; HDL cholesterol <0.9mmol/L; current smoker; known microalbuminuria; any evidence of previous vascular disease.

製品概要:

Visual Identification: White to off-white coloured, flat faced bevel edged round uncoated tablet debossed with 'H' &'17' on one side and plain on other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

認証ステータス:

Licence status A

承認日:

2011-10-06